Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

34 results
Display

An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model

Kwon JH, Kim KC, Cho MS, Kim HS, Sohn S, Hong YM

PURPOSE: Tumor necrosis factor (TNF)-alpha is thought to contribute to pulmonary hypertension. We aimed to investigate the effect of infliximab (TNF-alpha antagonist) treatment on pathologic findings and gene expression in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Bosentan Treatment on Angiotensin Converting Enzyme in Monocrotaline Induced Pulmonary Hypertension Rats

Kim SJ, Cha JH, Lee HR, Hong YM

BACKGROUND: Pulmonary artery hypertension is characterized by persistent increase of vascular resistance, and is associated with right ventricle failure. We investigated changes of plasma renin, serum aldosterone, angiotensin converting enzyme...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of TGF-beta and PDGF in Monocrotaline-Induced Pulmonary Hypertension in Rats

Cho MS, Cho SH, Yang WI, Han WS

  • KMID: 2073686
  • Korean J Pathol.
  • 1999 Aug;33(8):545-554.
Pulmonary vascular hypertension is characterized by migration and proliferation of smooth muscle cells accompanying abnormal synthesis and accumulation of extracellular proteins in vascular wall. The aim of this study is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Increased expression of nitric oxide synthases in left and right ventricular hypertrophy

Lee JU, Oh YW, Kim S, Kang DG, Lee WJ

  • KMID: 1606840
  • Korean J Physiol Pharmacol.
  • 2001 Feb;5(1):65-70.
The present study was aimed to explore pathophysiological implications of nitric oxide in the development of left and right ventricular hypertrophy. To induce selective left and right ventricular hypertrophy, rats were made two-kidney,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Assessment of Right Ventricular Function by Tissue Doppler Imaging in Pulmonary Arterial Hypertensive Rat

Hong JE, Kim KC, Hong YM

OBJECTIVES: Elevated pulmonary pressure and right ventricular (RV) dysfunction are the hallmarks of pulmonary vascular disease in animal models and human patients with pulmonary arterial hypertension (PAH). Monocrotaline models of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Enhanced Expression of Aldosterone Synthase and Adrenomedullin in Left and Right Ventricular Hypertrophy in Rats

Lee JU, Lee S, Kim S, Lee WJ

  • KMID: 1615003
  • Korean J Physiol Pharmacol.
  • 2002 Apr;6(2):121-126.
The pathophysiological implications of aldosterone and adrenomedullin in the cardiac ventricular hypertrophy were examined. Male Sprague-Dawley rats were treated with deoxycorticosterone acetate (DOCA)-salt and monocrotaline (MCT) to selectively elicit left...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes of Gene Expression after Bone Marrow Cell Transfusion in Rats with Monocrotaline-Induced Pulmonary Hypertension

Kim KC, Lee HR, Kim SJ, Cho MS, Hong YM

Pulmonary artery hypertension (PAH) causes right ventricular failure and possibly even death by a progressive increase in pulmonary vascular resistance. Bone marrow-derived mesenchymal stem cell therapy has provided an alternative...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Ambrisentan Therapy on the Expression of Endothelin Receptor, Endothelial Nitric Oxide Synthase and NADPH Oxidase 4 in Monocrotaline-induced Pulmonary Arterial Hypertension Rat Model

Lee H, Yeom A, Kim KC, Hong YM

BACKGROUND AND OBJECTIVES: Elevated endothelin (ET)-1 level is strongly correlated with the pathogenesis of pulmonary arterial hypertension (PAH). Expression level of nicotinamide adenine dinucleotide phosphate oxidase (NOX) 4 is increased...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gene Expression of Endothelin-1 and Endothelin Receptor A on Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment

Lim KA, Kim KC, Cho MS, Lee BE, Kim HS, Hong YM

BACKGROUND AND OBJECTIVES: Endothelin (ET)-1, a potent endothelium-derived vasoconstrictor peptide, has a potential pathophysiologic role in pulmonary hypertension. Bosentan, a dual ET receptor (ET(A)/ET(B)) antagonist, is efficacious in treatment of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gene Expressions of Nitric Oxide Synthase and Matrix Metalloproteinase-2 in Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment

Koo HS, Kim KC, Hong YM

BACKGROUND AND OBJECTIVES: Nitric oxide (NO) is a major endothelium dependent vasomediator and growth inhibitor. NO synthesis is catalyzed by endothelial nitric oxide synthase (eNOS), and NO can also produce...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats

Kim HJ, Yoo HY

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by vascular remodeling of pulmonary arteries (PAs) and increased vascular resistance in the lung. Monocrotaline (MCT), a toxic alkaloid, is widely...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of endothelin receptor blockade on monocrotaline-induced pulmonary hypertension in rats

Lim KA, Shim JY, Cho SH, Kim KC, Han JJ, Hong YM

PURPOSE: To examine the effect of bosentan, a dual endothelin receptor (ER) antagonist, on the development of monocrotaline (MCT)-induced pulmonary hypertension in rats by especially focusing on the pulmonary vascular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Apoptosis and Inflammation Associated Gene Expressions in Monocrotaline-Induced Pulmonary Hypertensive Rats after Bosentan Treatment

Hong YM, Kwon JH, Choi S, Kim KC

BACKGROUND AND OBJECTIVES: Vascular wall remodeling in pulmonary hypertension can be caused by an aberration in the normal balance between proliferation and apoptosis of endothelial cell in the pulmonary artery....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model

Lee YH, Kim KC, Cho MS, Hong YM

BACKGROUND AND OBJECTIVES: Simvastatin's properties are suggestive of a potential pathophysiologic role in pulmonary hypertension. The objectives of this study were to investigate changes of pulmonary pathology and gene expressions,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effect of sildenafil on right ventricular remodeling in a rat model of monocrotaline-induced right ventricular failure

Bae HK, Lee H, Kim KC, Hong YM

PURPOSE: Pulmonary arterial hypertension (PAH) leads to right ventricular failure (RVF) as well as an increase in pulmonary vascular resistance. Our purpose was to study the effect of sildenafil on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension

Lee DS, Kim YK, Jung YW

BACKGROUND AND OBJECTIVES: Pulmonary arterial hypertension (PAH) is a life threatening disease characterized by progressive pulmonary arterial occlusion which may ultimately result in death. Currently, the available treatments are diverse,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Resveratrol Attenuates Monocrotaline-Induced Pulmonary Hypertension in Rats

Lee DS, Jung JY, Jung YW

BACKGROUND AND OBJECTIVES : Resveratrol (RVT) is a polyphenolic phytoalexin, and it has been demonstrated to be capable of protecting against cardiovascular disease. The aim of this study was to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats

Lee JC, Kim KC, Yang YS, Oh W, Choi SJ, Choe SY, Hong YM

Pulmonary arterial hypertension (PAH) is associated with structural alterations of lung vasculature. PAH is still a devastating disease needing an aggressive therapeutic approach. Despite the therapeutic potential of human umbilical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Microarray Analysis in Pulmonary Hypertensive Rat Heart after Simvastatin Treatment

Kim YK, Kim KC, Hong YM

OBJECTIVES: Simvastatin has been reported to attenuate the development of pulmonary hypertension through increased apoptosis as well as reduced proliferation of smooth muscle cells in obstructive vascular lesions. Microarray experiment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Small Hairpin RNA Targeting Endothelin-Converting Enzyme-1 in Monocrotaline-Induced Pulmonary Hypertensive Rats

Son JS, Kim KC, Kim BK, Cho MS, Hong YM

The purpose of this study was to investigate the therapeutic effects of small hairpin RNA (shRNA) targeting endothelin-converting enzyme (ECE)-1 in monocrotaline (MCT)-induced pulmonary hypertensive rats. Ninty-four Sprague-Dawley rats were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr